News: Phase 3 program given thumbs up for it's lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma
finance.yahoo.com/ne...atory-110000104.html
finance.yahoo.com/ne...atory-110000104.html
Like, comment or follow if you like my ideas!